LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,000 | -27.3% | 2,800 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $11,000 | -15.4% | 2,800 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $13,000 | +18.2% | 2,800 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $11,000 | 0.0% | 2,800 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $11,000 | -15.4% | 2,800 | -9.7% | 0.00% | -25.0% |
Q1 2021 | $13,000 | +8.3% | 3,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $12,000 | 0.0% | 3,100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $12,000 | -14.3% | 3,100 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $14,000 | 0.0% | 3,100 | 0.0% | 0.01% | -28.6% |
Q1 2020 | $14,000 | – | 3,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |